beluuga.ai

Overview

Textiles and Apparels

TEIJIN LIMITED

Teijin Limited is a diversified materials and healthcare group operating through three core segments: Materials (high-performance materials including aramid fibers, polycarbonate resins, carbon fibers, and composite molding materials), Fiber & Products (polyester fibers, textiles, and functional fabrics), and Healthcare (pharmaceuticals, medical devices, and home healthcare services). The company's Materials segment serves global markets in automotive, aerospace, and protective applications, leveraging proprietary technologies such as Twaron and Technora aramid fibers and advanced composite materials through subsidiaries including Teijin Aramid B.V. and Teijin Automotive Technologies. The Healthcare segment, led by Teijin Pharma and Teijin Healthcare, provides prescription drugs and home oxygen therapy services primarily in Japan, while the company also pursues regenerative medicine and implantable medical devices through subsidiaries such as Japan Tissue Engineering Co., Ltd.

Activists: Effissimo Capital Management Pte. Ltd. 19.26%

Market Cap

¥310B

US$1.97B

¥487B

US$3.10B

Stock¥1,605.5▼-0.12%

US$1 = ¥157.05 (2026-10-22)

LTM EV/EBITDA

11.0

LTM EV/EBIT

LTM PER

LTM PBR

0.7

Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-4.9%pt

Oct 23, 25 – Oct 23, 26StockTOPIX

1Nov 5, 25Activist shareholder important proposal

2Nov 13, 25Effissimo Capital Management Pte. Ltd. changed stake (12.12%→13.2%)

3Dec 18, 25Effissimo Capital Management Pte. Ltd. changed stake (13.2%→14.21%)

4Mar 2, 26Effissimo Capital Management Pte. Ltd. changed stake (14.21%→15.27%)

5Mar 9, 26Effissimo large shareholding change report

MC → EV Bridge

AI Briefing

Generating insights…

Performance & Balance

Revenue 5Y (¥B)

EBITDA 5Y (¥B)

Net Income 5Y (¥B)

Capital Structure

56%

44%

EquityD/E 0.78xDebt

Liquidity vs Debt 5Y (¥B)▼ Net Debt

CashInv. Sec.Debt

Shareholders

Top 10 hold 49.6%

as of 2026-03-31 · Source: Annual Securities Report

The Master Trust Bank of Japan, Ltd. (Trust Account)

15.37%

GOLDMAN SACHS INTERNATIONAL (Standing Proxy: Goldman Sachs Japan Co., Ltd.)

6.88%

Custody Bank of Japan, Ltd. (Trust Account)

4.70%

MLI FOR SEGREGATED PB CLIENT (Standing Proxy: BofA Securities Japan Co., Ltd.)

4.54%

STATE STREET BANK AND TRUST COMPANY 505223 (Standing Proxy: Mizuho Bank, Ltd.)

3.78%

Nippon Life Insurance Company

3.65%

TEIJIN LIMITED Employee Stock Ownership Association

3.19%

JP JPMSE LUX RE CITIGROUP GLOBAL MARKETS L EQ CO (Standing Proxy: MUFG Bank, Ltd.)

2.77%

JPMSPLC CLIENT ASSETS SK JPY (Standing Proxy: Citibank, N.A., Tokyo Branch)

2.66%

BNY GCM CLIENT ACCOUNT JPRD AC ISG (FE-AC; Standing Proxy: MUFG Bank, Ltd.)

2.04%

Management

11 officers

Tetsushige UCHIKAWA

Representative Director, President and Executive Officer, CEO

See the career summary in (2) Directors, 1) List of Directors above

1966-01-18

Naohiko MORIYAMA

Representative Director, Senior Managing Executive Officer, in charge of Corporate Strategy and Planning

Same as above

1965-05-20

Yuji NAKAHARA

Director, Managing Executive Officer, in charge of Technology Strategy and responsible for Specialty Materials

Same as above

1969-06-23

Masaaki TSUYA

Independent Outside Director

Same as above

1952-06-22

Reiko KUSUSE

Independent Outside Director

Same as above

1965-10-02

Toichi MAEDA

Independent Outside Director

Same as above

1955-12-24

Tomoko TORII

Director (Full-time Audit and Supervisory Committee Member)

Same as above

1966-05-27

Naoki HAMAJIMA

Director (Full-time Audit and Supervisory Committee Member)

Apr 1993 Joined the Company Apr 2017 General Manager, Administration Department, Teijin Pharma Limited Apr 2018 General Manager, Finance Department, the Company Apr 2023 General Manager, Public Relations and IR Department, the Company Apr 2024 Assistant to Executive in charge of Corporate Strategy and Planning (in charge of Stakeholder Communications) and General Manager, Corporate Communications Department, the Company Jul 2024 Assistant to Executive in charge of Accounting and Finance (in charge of Accounting and Finance, Management Support Office), the Company Apr 2026 Attached to Executive in charge of Accounting and Finance, the Company Jun 2026 Director (Full-time Audit and Supervisory Committee Member), the Company (current)

1969-10-03

Koichi TSUJI

Independent Outside Director (Audit and Supervisory Committee Member)

Same as above

1957-04-10

Tamie MINAMI

Independent Outside Director (Audit and Supervisory Committee Member)

Same as above

1959-02-15

Yaeko TAKEOKA

Independent Outside Director (Audit and Supervisory Committee Member)

Same as above

1957-05-10

Large Shareholding Reports

Goldman Sachs International

2026-04-22

4.31%→1.28%